XML 29 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
SUBSEQUENT EVENTS (Details) (USD $)
3 Months Ended 0 Months Ended
Mar. 31, 2015
Mar. 12, 2015
Jan. 15, 2015
Apr. 02, 2015
Subsequent events        
Payment to acquire rights of pharmaceuticals products and certain related assets $ 500,000,000us-gaap_PaymentsToAcquireBusinessesGross      
Senior Secured Credit Facility | Three month LIBOR        
Subsequent events        
Term of credit facility   7 years    
Basis spread (as a percent)   9.75%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
   
Debt instrument, floor rate (as a percent)   1.00%us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
   
Amount that may be paid after the first year   100,000,000depo_DebtInstrumentPrincipalAmountThatMayBePaidAfterFirstYear
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
   
Debt issuance costs 500,000us-gaap_DebtIssuanceCosts
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
     
Janssen Pharmaceuticals, Inc.        
Subsequent events        
Payment to acquire rights of pharmaceuticals products and certain related assets     1,050,000,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= depo_JanssenPharmaceuticalsIncMember
 
Cash deposit to JPMorgan Chase Bank,N.A., (Escrow Agent)     500,000,000depo_BusinessCombinationCashEscrow
/ us-gaap_BusinessAcquisitionAxis
= depo_JanssenPharmaceuticalsIncMember
 
Remaining purchase price 550,000,000depo_RemainingPurchasePriceAmountNecessaryAfterEscrowDeposit
/ us-gaap_BusinessAcquisitionAxis
= depo_JanssenPharmaceuticalsIncMember
     
Subsequent event | Senior Secured Notes        
Subsequent events        
Proceeds from the issuance of debt       562,000,000us-gaap_ProceedsFromIssuanceOfDebt
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Principal amount       575,000,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Subsequent event | Janssen Pharmaceuticals, Inc. | Senior Secured Notes        
Subsequent events        
Proceeds from the issuance of debt       $ 550,000,000us-gaap_ProceedsFromIssuanceOfDebt
/ us-gaap_BusinessAcquisitionAxis
= depo_JanssenPharmaceuticalsIncMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember